Sign In
Buy CUE
$26.84
-3.56 (-11.71%)
At Close: Jul 31, 2026
CAMBRIDGE, Mass., Nov. 19, 2020 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company engineering a novel class of injectable biologics to selectively engag
Cue Biopharma Reports Third Quarter 2020 Results and CUE-101 Phase 1 Dose Escalation Trial Updates
04:01pm, Tuesday, 17'th Nov 2020
CAMBRIDGE, Mass., Nov. 17, 2020 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company engineering a novel class of injectable biologics designed to selectiv
Cue Biopharma to Present at Upcoming Investor Conferences in November 2020
08:00am, Wednesday, 11'th Nov 2020
CAMBRIDGE, Mass., Nov. 11, 2020 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company engineering a novel class of injectable biologics to selectively engag
Cue Biopharma to Host Business Update Call and Webcast
08:00am, Tuesday, 10'th Nov 2020
CAMBRIDGE, Mass., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company engineering a novel class of injectable biologics to selectively enga
Cue Biopharma Announces Presentations Highlighting Clinical Progress of CUE-101, Pipeline Progress of CUE-100 Series Immuno-STATs and Immuno-STAT Data for Infectious Disease Applications at the Society for Immunotherapy of Cancer's (SITC) 35th Anniversary Annual Meeting
08:00am, Monday, 09'th Nov 2020
CAMBRIDGE, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company engineering a novel class of injectable biologics to selectively engag
HHS invests $480 million in Cue Health to boost manufacturing of rapid coronavirus test
07:31pm, Tuesday, 13'th Oct 2020
"Cue's tests provide results in about 20 minutes with the kind of accuracy provided by lab tests that can take several days, adding to our dramatically expanding supply of rapid tests that can support
Fintech Machine Learning Leader Attunely Secures $9M in Funding
12:00am, Thursday, 24'th Sep 2020
Fintech Machine Learning Leader Attunely Secures $9M in Funding
Cue Biopharma, Inc. (NASDAQ: CUE), a clinical-stage biopharmaceutical company engineering a novel class of injectable biologics to selectively
Wall Street Breakfast: The Week Ahead
06:41am, Sunday, 13'th Sep 2020
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify.
Stocks To Watch: Apple, Snowflake, Pfizer And Moderna In Focus
08:40am, Saturday, 12'th Sep 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday
How To Predict Sales Growth
03:23pm, Tuesday, 08'th Sep 2020
I've found seven factors that correlate highly with future sales growth; this article explains each one.
Cue Biopharma, Inc. (CUE) CEO Dan Passeri on Q2 2020 Results - Earnings Call Transcript
12:23am, Tuesday, 01'st Sep 2020
Cue Biopharma, Inc. (NASDAQ:CUE) Q2 2020 Results Earnings Conference Call August 31, 2020, 04:30 PM ET Company Participants George Zavoico - Vice President, Investor Relations & Corporate Developm
Wall Street Breakfast: The Week Ahead
07:40am, Sunday, 30'th Aug 2020
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify.
Stocks To Watch: Nvidia, Intel And Zoom Look To Dazzle
08:00am, Saturday, 29'th Aug 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday
DeFi fintech studio Framework Labs raises $8M seed round » CryptoNinjas
03:29pm, Thursday, 27'th Aug 2020
Framework Labs, a fintech studio for the rapidly emerging “Decentralized Finance” or “DeFi” industry, has closed an $8 million seed round of financing led
